S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands

Benchmark (BMK) Competitors

GBX 46.10
-0.90 (-1.91%)
(As of 06:57 AM ET)

BMK vs. APH, BXP, AGY, ANCR, MXCT, BVXP, AVCT, NIOX, AMS, and TSTL

Should you be buying Benchmark stock or one of its competitors? The main competitors of Benchmark include Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), Allergy Therapeutics (AGY), Animalcare Group (ANCR), MaxCyte (MXCT), Bioventix (BVXP), Avacta Group (AVCT), NIOX Group (NIOX), Advanced Medical Solutions Group (AMS), and Tristel (TSTL). These companies are all part of the "medical" sector.

Benchmark vs.

Benchmark (LON:BMK) and Alliance Pharma (LON:APH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Alliance Pharma has a consensus price target of GBX 80.75, suggesting a potential upside of 95.52%. Given Alliance Pharma's higher probable upside, analysts clearly believe Alliance Pharma is more favorable than Benchmark.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Benchmark
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Alliance Pharma
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Benchmark has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Alliance Pharma has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Alliance Pharma has a net margin of -4.15% compared to Benchmark's net margin of -18.96%. Alliance Pharma's return on equity of -2.46% beat Benchmark's return on equity.

Company Net Margins Return on Equity Return on Assets
Benchmark-18.96% -8.05% -0.79%
Alliance Pharma -4.15%-2.46%2.99%

Benchmark received 33 more outperform votes than Alliance Pharma when rated by MarketBeat users. Likewise, 72.62% of users gave Benchmark an outperform vote while only 62.08% of users gave Alliance Pharma an outperform vote.

CompanyUnderperformOutperform
BenchmarkOutperform Votes
236
72.62%
Underperform Votes
89
27.38%
Alliance PharmaOutperform Votes
203
62.08%
Underperform Votes
124
37.92%

Alliance Pharma has higher revenue and earnings than Benchmark. Alliance Pharma is trading at a lower price-to-earnings ratio than Benchmark, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Benchmark£155.53M2.19-£24.44M-£0.03-1,536.67
Alliance Pharma£170.05M1.31-£7.06M-£0.01-4,135.20

In the previous week, Alliance Pharma had 1 more articles in the media than Benchmark. MarketBeat recorded 1 mentions for Alliance Pharma and 0 mentions for Benchmark. Alliance Pharma's average media sentiment score of 0.67 beat Benchmark's score of 0.00 indicating that Alliance Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Benchmark Neutral
Alliance Pharma Positive

92.1% of Benchmark shares are owned by institutional investors. Comparatively, 71.8% of Alliance Pharma shares are owned by institutional investors. 5.8% of Benchmark shares are owned by insiders. Comparatively, 11.7% of Alliance Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Alliance Pharma beats Benchmark on 11 of the 17 factors compared between the two stocks.


Get Benchmark News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMK vs. The Competition

MetricBenchmarkDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£340.91M£1.10B£4.97B£1.34B
Dividend YieldN/A2.97%2.87%12.10%
P/E Ratio-1,536.671,423.88183.261,689.23
Price / Sales2.199,944.502,943.31380,117.17
Price / Cash7.419.8896.0332.82
Price / Book1.323.324.462.50
Net Income-£24.44M£113.36M£114.21M£182.66M
7 Day Performance0.22%0.90%4.26%-0.19%
1 Month Performance2.67%7.00%8.76%-0.28%
1 Year Performance21.32%10.15%12.16%5.86%

Benchmark Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APH
Alliance Pharma
3.0851 of 5 stars
GBX 40.70
+0.1%
GBX 80.75
+98.4%
-38.8%£219.94M£170.05M-4,070.00285
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 40.30
+0.8%
N/A-10.0%£179.78M£41.65B503.755,700
AGY
Allergy Therapeutics
0 of 5 stars
GBX 2.50
-3.8%
N/A-61.6%£119.25M£59.59M-41.67612Gap Up
ANCR
Animalcare Group
0 of 5 stars
GBX 195.90
+1.0%
N/A+27.0%£117.76M£70.04M9,795.00220Gap Up
MXCT
MaxCyte
0 of 5 stars
GBX 364.40
+1.2%
GBX 1,060
+190.9%
-7.7%£377.45M£38.05M-1,256.55125
BVXP
Bioventix
0 of 5 stars
GBX 5,084
+3.2%
N/A+28.4%£265.39M£12.82M3,217.7212
AVCT
Avacta Group
0 of 5 stars
GBX 90.70
-0.9%
N/A-59.7%£261.48M£16.02M-566.88120
NIOX
NIOX Group
0 of 5 stars
GBX 61
+1.7%
GBX 77
+26.2%
+33.3%£257.03M£34.60M3,050.0092Gap Down
AMS
Advanced Medical Solutions Group
1.8064 of 5 stars
GBX 208.25
-0.4%
GBX 293
+40.7%
-16.0%£452.59M£129.11M2,313.89800News Coverage
TSTL
Tristel
0.2498 of 5 stars
GBX 448.88
-0.2%
GBX 390
-13.1%
+47.4%£212.95M£36.01M4,987.56208Dividend Cut

Related Companies and Tools

This page (LON:BMK) was last updated on 3/1/2024 by MarketBeat.com Staff